Grove Biopharma Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$36M
- Investors
-
13
Grove Biopharma General Information
Description
Operator of a modality biotechnology company intended to treat unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. The company uses artificial intelligence and precision polymer chemistry to create hybrid synthetic protein mimetics and also offers materials science services to peptide therapeutic challenges, enabling medical professionals with the discovery and development of a new class of synthetic biologic drug modality to access challenging drug targets.
Contact Information
Website
www.grovebiopharma.comCorporate Office
- 400 North Aberdeen Street
- Chicago, IL 60642
- United States
Corporate Office
- 400 North Aberdeen Street
- Chicago, IL 60642
- United States
Grove Biopharma Timeline
Grove Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 23-Apr-2025 | $36M | Completed | Startup | ||
| 3. Early Stage VC (Series A) | 31-Dec-2023 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 30-Jun-2021 | $4.5M | $4.5M | Completed | Clinical Trials - General | |
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Grove Biopharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 4,150,230 | $0.001000 | $2.47 | $2.47 | 1x | $2.47 | 19.98% | |
| Series A-3 | 64,893 | $0.001000 | $2.31 | $2.31 | 1x | $2.31 | 0.31% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Grove Biopharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Grove Biopharma Patents
Grove Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024076976-A1 | Nrf2-derived polypeptides and protein-like polymer conjugates thereof | Inactive | 05-Oct-2022 | ||
| EP-4493577-A1 | Inhibition of myc using high-density brush polymers | Pending | 14-Mar-2022 | ||
| US-20260263607-A1 | Inhibition of myc using high-density brush polymers | Pending | 14-Mar-2022 | ||
| WO-2023178074-A1 | Inhibition of myc using high-density brush polymers | Inactive | 14-Mar-2022 | C07K17/08 |
Grove Biopharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Grove Biopharma Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DCVC Bio | Venture Capital | Minority | ||
| Gradiant | VC-Backed Company | Minority | ||
| InVivium Capital | Venture Capital | Minority | ||
| Lilly USA | Corporation | Minority | ||
| Mansueto Investments | Corporation | Minority |
Grove Biopharma FAQs
-
When was Grove Biopharma founded?
Grove Biopharma was founded in 2020.
-
Where is Grove Biopharma headquartered?
Grove Biopharma is headquartered in Chicago, IL.
-
What is the size of Grove Biopharma?
Grove Biopharma has 9 total employees.
-
What industry is Grove Biopharma in?
Grove Biopharma’s primary industry is Drug Discovery.
-
Is Grove Biopharma a private or public company?
Grove Biopharma is a Private company.
-
What is the current valuation of Grove Biopharma?
The current valuation of Grove Biopharma is .
-
What is Grove Biopharma’s current revenue?
The current revenue for Grove Biopharma is .
-
How much funding has Grove Biopharma raised over time?
Grove Biopharma has raised $44M.
-
Who are Grove Biopharma’s investors?
DCVC Bio, Gradiant, InVivium Capital, Lilly USA, and Mansueto Investments are 5 of 13 investors who have invested in Grove Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
